Company intelligence
Kiora Pharmaceuticals, Inc.
Developing advanced therapies for retinal disease
Biotechnology
Encinitas, US
17 employees
Founded 2013
2 public signals
About Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc. (Kiora) is a clinical stage biotech company focusing on novel therapeutics for the treatment of retinal diseases. Publicly traded on the NASDAQ under KPRX, our mission is to help patients improve and/or restore vision.
Verified activity
Signals from Kiora Pharmaceuticals, Inc.
2 published signals
People
Kiora Pharmaceuticals, Inc. welcomed Keith Lane, MBA as Executive Vice President of Clinical Development and Regulatory Affairs.
Reported by Kiora Pharmaceuticals, Inc.
Partnerships
Kiora Pharmaceuticals, Inc. signed a licensing agreement with Chong Kun Dang Pharm. Corporation for the South Korean development and commercialization rights to KIO-301 for ophthalmic indications.
Reported by Kiora Pharmaceuticals, Inc.